This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
Avatar

ASCO® 2024 Insights: "Analyses of TTX-080, a First-in-Class HLA-G Antagonist, in Combination With Cetuximab in Patients With mCRC and HNSCC"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Susanna Ulahannan
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Susanna Ulahannan
44 views
July 3, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Featured Video

20:14
Exelixis

Hypothetical Patient Case: RAI-R Metastatic Differentiated Thyroid C…

Feat. R. Alter, R. Shameem

2024 ASCO® Annual Meeting Insights Hub: Head & Neck Videos

19:41

ASCO® 2024 H&N Cancer Highlights: Key Insights From Clinical Trials

2024 ASCO® Annual Meeting Insights Hub

K. Kerrigan

194 views

·

2 months ago
08:06

ASCO® 2024 Insights: "FIREFLY-1 Trial - Type II RAF Inhibitor Tovora…

2024 ASCO® Annual Meeting Insights Hub

D. Ziegler

145 views

·

4 months ago
06:05

ASCO® 2024 Insights: "Petosemtamab With Pembro as 1L Treatment of Re…

2024 ASCO® Annual Meeting Insights Hub

C. Perez

85 views

·

4 months ago
View All

Recommended

14:57

The Radiologist's Approach to Assessing Cancer Risk of Thyroid Nodul…

Penn Medicine

J. Langer

4.8K views

·

1 year ago
27:51

Less is More: Active Surveillance In Low-Risk Papillary Thyroid Canc…

Keck School of Medicine of USC

R. Michael Tuttle

830 views

·

5 months ago
27:04

Cancer Screening Molecular Tools

Fengting Yan

2.5K views

·

11 months ago
21:12

ASCO® 2024 H&N Highlights: "Key Trial Updates in H&N Cancers"

2024 ASCO® Annual Meeting Insights Hub

N. Saba

1.0K views

·

5 months ago
03:08

The Importance of 1L Biomarkers in CRC

Nicholas DeVito

715 views

·

5 months ago
14:19

ESMO 2024 Summary: Late-Line Therapy in mCRC - How to Choose

2024 ESMO Annual Meeting Insights Hub

H. Hochster

397 views

·

1 month ago
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views

·

7 months ago
18:21

New

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

373 views

·

3 weeks ago
04:40

ESMO 2024 Summary: Neoadjuvant Colon Cancer Treatment - Recent Clini…

2024 ESMO Annual Meeting Insights Hub

J. Taieb

290 views

·

1 month ago
24:57

ASCO® 2024 Summary: "CRC Key Studies Including TRANSMET, CheckMate 8…

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

555 views

·

5 months ago
16:57

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

678 views

·

5 months ago
25:55

ASCO® 2024 Summary: "News in Head&Neck Cancers"

2024 ASCO® Annual Meeting Insights Hub

P. Bossi

483 views

·

5 months ago
13:29

Treating KRAS-Mutated mCRC

Ibrahim Sahin

694 views

·

8 months ago
22:06

ESMO 2024 Summary: Head & Neck Cancer Take Home Messages

2024 ESMO Annual Meeting Insights Hub

P. Bossi

310 views

·

1 month ago
23:58

ASCO GI 2023 Key Studies

ASCO GI 2023 Conference Coverage

R. Kim, R. Mehta

3.1K views

·

1 year ago
15:51

2024 Updates on 1L MSI-H/dMMR mCRC and Using ctDNA MRD Testing in Ea…

Total Health

A. Grothey

488 views

·

8 months ago
13:27

ESMO 2024 Summary: Head & Neck Cancer Highlights

2024 ESMO Annual Meeting Insights Hub

N. Saba

305 views

·

1 month ago
14:49

Year in Review: Precision Medicine

Vivek Subbiah

945 views

·

10 months ago
26:19

Nasopharyngeal Carcinoma: Clinical Overview & Disease Management

Ammar Sukari

1.3K views

·

1 year ago
18:07

NOS ASCO® 2023 Review: Nasopharynx Cancer

Nebraska Oncology Society

E. Sherman

1.8K views

·

1 year ago
AUTOPLAY